Skip to main content

Winrevair Disease Interactions

There are 2 disease interactions with Winrevair (sotatercept).

Moderate

Sotatercept (applies to Winrevair) bleeding

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Thrombocytopenia

Sotatercept may cause severe thrombocytopenia and increase the risk of bleeding. Do not initiate treatment with sotatercept in patients with platelet counts below 50,000/mm3. Do not administer sotatercept in patients who are experiencing serious bleeding.

Moderate

Sotatercept (applies to Winrevair) hepatic impairment

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

The effect of hepatic impairment on the pharmacokinetics of sotatercept has not been studied.

Switch to professional interaction data

Winrevair drug interactions

There are 2 drug interactions with Winrevair (sotatercept).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.